These indicators, including the CD8/CD133 and CD8/TB indices, as well as the CD133-adjacent CD8+ T and TB-adjacent CD8+ T cells, have been successfully established as “anti-tumor” and “pro-tumor” models. This evidence concerns the gene PROM1 and neoplasm.